A group randomized trial to improve safe use of nonsteroidal anti-inflammatory drugs

American Journal of Managed Care

Volumn 11, Issue 9, 2005, Pages 537-543

  Curtis, Jeffrey R ^a   Olivieri, Jason ^b   Allison, Jeroan J ^c   Gaffo, Angelo ^c   Juarez, Lucia ^c   Kovac, Stacey H ^d   Person, Sharina ^c   Saag, Kenneth G ^a,e  

^a The University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^c University of Alabama at Birmingham   (United States)

^d DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DISEASE MODIFYING ANTIRHEUMATIC DRUG; DIURETIC AGENT; MISOPROSTOL; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR; ROFECOXIB;

ADULT; ARTICLE; BLOOD CELL COUNT; CLINICAL TRIAL; CONSULTATION; CONTINUING EDUCATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG INDICATION; DRUG SAFETY; GASTROINTESTINAL SYMPTOM; GENERAL PRACTITIONER; HEALTH CARE ORGANIZATION; HUMAN; MAJOR CLINICAL STUDY; MANAGED CARE; MEDICAL AUDIT; MEDICAL EDUCATION; MEDICAL PRACTICE; MEDICAL RECORD; MEDICAL SPECIALIST; PATIENT MONITORING; PERFORMANCE; PHYSICIAN; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SIDE EFFECT;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CLUSTER ANALYSIS; COHORT STUDIES; CYTOPROTECTION; FEMALE; HUMANS; MALE; MEDICAL AUDIT; MIDDLE AGED; QUALITY INDICATORS, HEALTH CARE; SAFETY MANAGEMENT; UNITED STATES;

EID: 25444502639     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Baum C, Kennedy D, Forbes M. Utilization of nonsteroidal antiinflammatory drugs. Arthritis Rheum. 1985;28:686-692.
2. Roth S. Non-steroidal anti-inflammatory drugs, gastropathy, deaths and medical practice. Ann Intern Med. 1988;109:353-354.
3. Wolfe MM, Lichtenstein DR, Singh G. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N Engl J Med. 1999;340:1888-1899.
4. Fries JF, Bruce B. Rates of serious gastrointestinal events from low dose use of acetylsalicylic acid, acetaminophen, and ibuprofen in patients with osteoarthritis and rheumatoid arthritis. J Rheumatol. 2003;30:2226-2233.
5. Fries JF, Murtagh K, Bennett M, Zatarain E, Lingala B, Bruce B. The rise and decline of nonsteroidal antiinflammatory drug associated gastropathy in rheumatoid arthritis. Arthritis Rheum. 2004;50:2433-2440.
6. Hanlon J, Schmader K, Boult C, et al. Use of inappropriate prescription drugs by older people. J Am Geriatr Soc. 2002;50:26-34.
7. Tannenbaum H, Davis P, Russell AS, et al. An evidence-based approach to prescribing NSAIDs in musculoskeletal disease: a Canadian consensus. Canadian NSAID Consensus Participants. Can Med Assoc J. 1996;155:77-88.
8. Henrich W, Agodoa L, Barrett B. Analgesics and the kidney: summary and recommendations to the Scientific Advisory Board of the National Kidney Foundation from an Ad Hoc Committee of the National Kidney Foundation. Am J Kidney Dis. 1996;27:162-165.
9. Lanza FL. A guideline for the treatment and prevention of NSAID-induced ulcers. Members of the Ad Hoc Committee on Practice Parameters of the American College of Gastroenterology. Am J Gastroenterol. 1998;93:2037-2046.
10. Guidelines for monitoring drug therapy in rheumatoid arthritis. American College of Rheumatology Ad Hoc Committee on Clinical Guidelines. Arthritis Rheum. 1996;39:723-731.
11. MacLean CH, Louie R, Leake B, et al. Quality of care for patients with rheumatoid arthritis. JAMA. 2000;284:984-992.
12. Rothenberg R, Holcomb J. Guidelines for monitoring of NSAIDs. Who listened? J Clin Rheum. 2000;6:258-265.
13. Patino F, Olivieri J, Allison J, et al. Nonsteroidal antiinflammatory drug toxicity monitoring and safety practices. J Rheumatol. 2003;30:2680-2688.
14. Davis D, Thomson M, Oxman A, Haynes R. Changing physician performance: a systematic review of the effect of continuing medical education strategies. JAMA. 1995;274:700-705.
15. Bero LA, Grilli R, Grimshaw JM, Harvey E, Oxman AD, Thomson MA. Closing the gap between research and practice: an overview of systematic reviews of interventions to promote the implementation of research findings. The Cochrane Effective Practice and Organization of Care Review Group. BMJ (Clinical Research ed). 1998;317(7156):465-468.
16. Lanza F. A guideline for the treatment and prevention of NSAID-induced ulcers. Members of the Ad Hoc Committee on Practice Parameters of the American College of Gastroenterology. Am J Gastroenterol. 1998;39:2037-2046.
17. Kiefe C, Allison J, Williams O, Person S, Weaver M, Weissman N. Improving quality improvement: a randomized trial of Achievable Benchmark of Care feedback. JAMA. 2001;285:2871-2879.
18. Murray DM. Design and Analysis of Group-randomized Trials. New York, NY: Oxford University Press; 1998.
19. Freemantle N, Harvey E, Wolf F, Grimshaw J, Grilli R, Bero L. Printed educational materials: effects on professional practice and health care outcomes. Cochrane Database Syst Rev. 2000.
20. David D, O'Brian M, Freemantle N, Wolf F, Mazmanian P, Taylor-Vaisey A. Impact of formal continuing medical education: do conferences, workshops, rounds, and other traditional continuing education activities change physician behavior or health care outcomes? JAMA. 1999;282:867-874.
21. Hulscher M, Wensing M, Van der Weijden T, Grol R. Interventions to implement interventions in primary care. Cochrane Database Syst Rev. 2004;2.
22. Thomson O'Brien M, Oxman A, Haynes R, Davis D, Freemantle N, Harvey E. Local opinion leaders: effects on professional practice and health care outcomes (Cochrane Review). The Cochrane Library. Chichester, UK: John Wiley & Sons, Ltd; 2004.
23. Thomson O'Brien M, Oxman A, Davis D, Haynes R, Freemantle N, Harvey E. Educational outreach visits: effects on professional practice and health care outcomes (Cochrane Review). The Cochrane Library. Chichester, UK: John Wiley & Sons, Ltd; 2004.
24. Thomson O'Brien M, Oxman A, Davis D, Haynes R, Freemantle N, Harvey E. Audit and feedback versus alternative strategies. Cochrane Database Syst Rev. 2004;2.
25. Jamtvedt G, Young J, Kristoffersen D, Thomson O'Brien M, Oxman A. Audit and feedback: effects on professional practice and health care outcomes (Cochrane Review). The Cochrane Library. Chichester, UK: John Wiley & Sons, Ltd; 2004.
26. National Committee for Quality Assurance. The State of Health Care Quality: 2004. Available at: http://www.ncqa.org/about/about.htm. Accessed July 12, 2005.
27. Singh G, Ramey DR, Triadafilopoulos G, Brown B, Balise R. GI score: a simple self-assessment instrument to quantify the risk of serious NSAID related GI complications in RA and OA. Arthritis Rheum. 1998;41:S75.